AngioDynamics, Inc. (ANGO)
NASDAQ: ANGO · Real-Time Price · USD
9.06
+0.22 (2.49%)
Aug 13, 2025, 4:00 PM - Market closed
AngioDynamics Income Statement
Financials in millions USD. Fiscal year is June - May.
Millions USD. Fiscal year is Jun - May.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 | 2016 - 2020 |
| Revenue | 292.5 | 303.91 | 338.75 | 316.22 | 291.01 | Upgrade
|
| Revenue Growth (YoY) | -3.76% | -10.28% | 7.13% | 8.66% | 10.17% | Upgrade
|
| Cost of Revenue | 134.79 | 149.22 | 164.51 | 150.49 | 134.22 | Upgrade
|
| Gross Profit | 157.71 | 154.7 | 174.25 | 165.73 | 156.79 | Upgrade
|
| Selling, General & Admin | 145.6 | 144.18 | 144.45 | 134.01 | 117.22 | Upgrade
|
| Research & Development | 25.85 | 31.32 | 29.69 | 30.48 | 36.39 | Upgrade
|
| Operating Expenses | 181.77 | 188.54 | 192.93 | 183.95 | 171.75 | Upgrade
|
| Operating Income | -24.06 | -33.84 | -18.68 | -18.22 | -14.96 | Upgrade
|
| Interest Expense | - | - | -2.7 | -0.69 | -0.86 | Upgrade
|
| Interest & Investment Income | 0.98 | 1.61 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 4.94 | -0.82 | -0.55 | -0.79 | 0.09 | Upgrade
|
| EBT Excluding Unusual Items | -18.14 | -33.05 | -21.94 | -19.7 | -15.73 | Upgrade
|
| Merger & Restructuring Charges | -15.4 | -18.13 | -1.46 | -0.7 | -0 | Upgrade
|
| Impairment of Goodwill | - | -159.48 | -14.55 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 54.5 | - | - | -0.39 | Upgrade
|
| Asset Writedown | - | - | - | - | -13.95 | Upgrade
|
| Legal Settlements | -0.72 | -34.94 | -10 | -7.63 | -6.16 | Upgrade
|
| Other Unusual Items | 0.22 | -0.55 | -6.5 | -1.93 | 0.19 | Upgrade
|
| Pretax Income | -34.03 | -191.64 | -54.44 | -29.95 | -36.05 | Upgrade
|
| Income Tax Expense | -0.04 | -7.29 | -2 | -3.4 | -4.5 | Upgrade
|
| Earnings From Continuing Operations | -33.99 | -184.35 | -52.44 | -26.55 | -31.55 | Upgrade
|
| Net Income | -33.99 | -184.35 | -52.44 | -26.55 | -31.55 | Upgrade
|
| Net Income to Common | -33.99 | -184.35 | -52.44 | -26.55 | -31.55 | Upgrade
|
| Shares Outstanding (Basic) | 41 | 40 | 39 | 39 | 38 | Upgrade
|
| Shares Outstanding (Diluted) | 41 | 40 | 39 | 39 | 38 | Upgrade
|
| Shares Change (YoY) | 1.67% | 1.78% | 1.21% | 1.74% | 1.00% | Upgrade
|
| EPS (Basic) | -0.83 | -4.59 | -1.33 | -0.68 | -0.82 | Upgrade
|
| EPS (Diluted) | -0.83 | -4.59 | -1.33 | -0.68 | -0.82 | Upgrade
|
| Free Cash Flow | -20.31 | -35.69 | -9.13 | -22.9 | 10.38 | Upgrade
|
| Free Cash Flow Per Share | -0.50 | -0.89 | -0.23 | -0.59 | 0.27 | Upgrade
|
| Gross Margin | 53.92% | 50.90% | 51.44% | 52.41% | 53.88% | Upgrade
|
| Operating Margin | -8.23% | -11.14% | -5.51% | -5.76% | -5.14% | Upgrade
|
| Profit Margin | -11.62% | -60.66% | -15.48% | -8.39% | -10.84% | Upgrade
|
| Free Cash Flow Margin | -6.94% | -11.74% | -2.70% | -7.24% | 3.57% | Upgrade
|
| EBITDA | -1.66 | -8.53 | 12.19 | 11.13 | 10.95 | Upgrade
|
| EBITDA Margin | -0.57% | -2.81% | 3.60% | 3.52% | 3.76% | Upgrade
|
| D&A For EBITDA | 22.4 | 25.31 | 30.87 | 29.35 | 25.92 | Upgrade
|
| EBIT | -24.06 | -33.84 | -18.68 | -18.22 | -14.96 | Upgrade
|
| EBIT Margin | -8.23% | -11.14% | -5.51% | -5.76% | -5.14% | Upgrade
|
Updated Jul 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.